Related references
Note: Only part of the references are listed.Repaglinicle/bedtime NPH insulin is comparable to twice-daily NPH insulin
A Panelo et al.
DIABETES CARE (2005)
Drug therapy: Insulin analogues
IB Hirsch
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes
A Holstein et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2003)
Glimepiride combined with morning insulin glargine, bedtime neutral protamine Hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes -: A randomized, controlled trial
A Fritsche et al.
ANNALS OF INTERNAL MEDICINE (2003)
Insulin glargine: A systematic review of a long-acting insulin analogue
F Wang et al.
CLINICAL THERAPEUTICS (2003)
Acarbose improves glycemic control in insulin-treated Asian type 2 diabetic patients: Results from a multinational, placebo-controlled study
CM Hwu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2003)
Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with Type 2 diabetes inadequately controlled with oral hypoglycaemic agents
NJ Furlong et al.
DIABETIC MEDICINE (2003)
The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
MC Riddle et al.
DIABETES CARE (2003)
Sulfonylurea inadequacy - Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)
A Wright et al.
DIABETES CARE (2002)
Effect of repaglinide addition to NPH insulin monotherapy on glycemic control in patients with type 2 diabetes
DA de luis et al.
DIABETES CARE (2001)
Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study
G Mertes
DIABETES RESEARCH AND CLINICAL PRACTICE (2001)
Combination therapies with insulin in type 2 diabetes
H Yki-Järvinen
DIABETES CARE (2001)
Basal insulin therapy in type 2 diabetes - 28-week comparison of insulin glargine (HOE 901) and NPH insulin
J Rosenstock et al.
DIABETES CARE (2001)
Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 1 diabetes
H Yki-Järvinen et al.
DIABETES CARE (2000)